Broquinaldol,
15599-52-7,
5,7-dibromo-2-methylquinolin-8-ol,
5,7-Dibromo-8-hydroxyquinaldine,
UNII-519JDS089K,
8-Quinolinol, 5,7-dibromo-2-methyl-,
5,7-Dibromo-2-methyl-8-quinolinol,
519JDS089K,
8-Quinolinol,5,7-dibromo-2-methyl-,
NCGC00160566-01,
DSSTox_CID_26235,
DSSTox_RID_81462,
DSSTox_GSID_46235,
J-650347,
Brochinaldol,
Broquinaldolum,
Broquinaldol [INN],
CAS-15599-52-7,
Broquinaldolum [Latin],
Broquinaldolum [INN-Latin],
5,7-Dibrom-2-methyl-8-chinolinol,
EINECS 239-680-0,
AC1L23MN,
AC1Q2P6T,
AC1Q2P6U,
NCIOpen2_009486,
SCHEMBL2110667,
ZINC1061,
CHEMBL1394319,
DTXSID9046235,
CTK4C8919,
BNACJQWJZKPAPV-UHFFFAOYSA-N,
8-Quinolinol,7-dibromo-2-methyl-,
NSC85838,
Tox21_111904,
5,7-Bibromo-2-methylquinolin-8-ol,
NSC-85838,
SBB057821,
5,7-dibromo-2-methyl-quinolin-8-ol,
AKOS003391968,
Tox21_111904_1,
FCH1320026,
MCULE-5296588218,
NCGC00160566-02,
5,7-dibromo-8-hydroxy-2-methylquinoline,
ZB000232,
5,7-Dibromo-2-methyl-8-quinolinol, 97%,
DB-030213,
FT-0705200,
ST50409278,
Broxaldine,
C10H7Br2NO,
C10-H7-Br2-N-O,
CID65620,
3684-46-6,